title: Riociguat recommended by CHMP for approval in the EU for use in two forms of pulmonary hypertension.
authors.forename: Michael
authors.initials: M
authors.lastname: Dowdall
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D017277:Drug Approval; D005062:European Union; D017079:Exercise Tolerance / Q000502:physiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000959:Antihypertensive Agents; D011720:Pyrazoles; D011743:Pyrimidines; C542595:riociguat